Covered recipient · General Payments record
KIRA RACINE GROVES
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$1,769.26
- Reported across 103 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $472.57 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $133.66 | 10 |
| PFIZER INC. | $73.68 | 4 |
| Astellas Pharma US Inc | $63.44 | 4 |
| Acerta Pharma LLC | $49.77 | 3 |
| Abbott Laboratories | $45.42 | 2 |
| Novo Nordisk AS | $36.10 | 2 |
| GlaxoSmithKline, LLC. | $30.70 | 1 |
| Merck Sharp & Dohme Corporation | $23.71 | 1 |
| Axsome Therapeutics, Inc. | $16.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.50 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124824397 | CMS |
| Abbott Laboratories | $22.92 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124824399 | CMS |
| ABBVIE INC. | $15.88 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103844272 | CMS |
| ABBVIE INC. | $33.18 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103844274 | CMS |
| ABBVIE INC. | $8.13 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103844276 | CMS |
| ABBVIE INC. | $13.90 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103844278 | CMS |
| ABBVIE INC. | $6.74 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103844280 | CMS |
| ABBVIE INC. | $9.52 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103844282 | CMS |
| ABBVIE INC. | $8.38 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103844284 | CMS |
| ABBVIE INC. | $10.96 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103844286 | CMS |
| ABBVIE INC. | $14.13 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103844288 | CMS |
| ABBVIE INC. | $12.84 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103844290 | CMS |
| Astellas Pharma US Inc | $15.08 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139315422 | CMS |
| Astellas Pharma US Inc | $13.08 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139325612 | CMS |
| Astellas Pharma US Inc | $16.20 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139383634 | CMS |
| Astellas Pharma US Inc | $19.08 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139427926 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.37 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105869191 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.76 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105730709 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.64 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105272155 | CMS |
| Axsome Therapeutics, Inc. | $16.09 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148296728 | CMS |
| GlaxoSmithKline, LLC. | $30.70 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116636054 | CMS |
| Merck Sharp & Dohme LLC | $23.71 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141780453 | CMS |
| Novo Nordisk Inc | $19.45 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096822547 | CMS |
| Novo Nordisk Inc | $16.65 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096610536 | CMS |
| PFIZER INC. | $19.78 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131088088 | CMS |
| PFIZER INC. | $15.83 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131368940 | CMS |
| PFIZER INC. | $17.46 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131454736 | CMS |
| PFIZER INC. | $20.61 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131459023 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.